| |
| Trade Name | Reclaim DBS Therapy for Obsessive Compulsive Disorder (OCD) System |
| Classification Name | deep brain stimulator for obsessive compulsive disorder (ocd) |
| Generic Name | deep brain stimulator for obsessive compulsive disorder (ocd) |
| Applicant |
| Medtronic Inc.,Neurological Division. |
| 7000 central ave., northeast |
| minneapolis, MN 55432 |
|
| HDE Number | H050003 |
| Supplement Number | S169 |
| Date Received | 09/20/2017 |
| Decision Date | 10/20/2017 |
| Product Code | |
| Advisory Committee |
Neurology |
| Supplement Type | special (immediate track) |
| Supplement Reason | labeling change - indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | No |
Approval Order Statement Addition of new safety information (tunneling procedure unintended nerve tissue injury warning and adverse event, loss of coordination precaution, weight gain/loss adverse event) and safety enhancement clarifications (update guidance on avoiding damage to the neurostimulator (physician labeling), clarify text that accompanies the figure for accurate right and left hemisphere lead-extension connection when placing dual lead systems (physician labeling), remove incorrect length of the dbs lead placed under the scalp (patient labeling)). |